Omalizumab treats multi-food allergy better than oral immunotherapy, study finds
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy
Producer Bob Ezrin Renounces U.S. Citizenship, Returns Home to Canada Billboard...
Mercedes-Benz is planning to reduce its workforce in China by up to 15%, primarily affecting its financing and sales units.
AUD/JPY extends its losses for the second successive day, trading around 95.60 during the Asian hours on Thursday...
Farmers are receiving less of what consumers spend on food, as modern food systems increasingly direct costs toward value-added components
In a joint appearance Monday morning, President-elect Donald Trump and Masayoshi Son, chairman and CEO of the Japanese technology conglomerate
It's the first time that Pope Francis has openly urged for an investigation of genocide allegations over Israel's actions in
Battery-powered tools and equipment deliver industrial-grade performance and longer battery life...
Fans are confused after Young Thug seemingly tweeted and deleted a shot directly at Gunna. On Saturday (Nov. 9), prior
The plant-based seafood market is underserved â enter BettaF!sh. This week we're discovering how founder, Deniz Ficicioglu, is revolutionising the
No posts found.